PharmaShots | Incisive News in 3 Shots

Subscribe Now

PsA

Sandoz's Erelzi (etanercept- biosimilar) Receives Health Canada Approval for Psoriatic Arthritis (PsA) in Adults

Sandoz's Erelzi (etanercept- biosimilar) Receives Health Canada Approval for Psoriatic Arthritis (PsA) in Adults

January 22, 2019

Sandoz's Hymiroz (adalimumab-adaz) Receives the US FDA Approval for Treatment of Chronic Autoimmune Diseases

Sandoz's Hymiroz (adalimumab-adaz) Receives the US FDA Approval for Treatment of Chronic Autoimmune Diseases

October 31, 2018

UCB Reports Improved Results of Extended P-IIb BE ACTIVE study for Bimekizumab in Patients with Psoriatic Arthritis (PsA) Patients

UCB Reports Improved Results of Extended P-IIb BE ACTIVE study for Bimekizumab in Patients with Psoriatic Arthritis (PsA) Patients

October 24, 2018

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us